| Measures of frailty in population-based studies: an overview K Bouillon, M Kivimaki, M Hamer, S Sabia, EI Fransson, A Singh-Manoux, ... BMC geriatrics 13 (1), 64, 2013 | 611 | 2013 |
| Long-term cardiovascular mortality after radiotherapy for breast cancer K Bouillon, N Haddy, S Delaloge, JR Garbay, JP Garsi, P Brindel, ... Journal of the American College of Cardiology 57 (4), 445-452, 2011 | 283 | 2011 |
| Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116 000 European men and women K Heikkilä, ST Nyberg, T Theorell, EI Fransson, L Alfredsson, JB Bjorner, ... Bmj 346, f165, 2013 | 226 | 2013 |
| Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus … G Maura, PO Blotière, K Bouillon, C Billionnet, P Ricordeau, F Alla, ... Circulation, CIRCULATIONAHA. 115.015710, 2015 | 206 | 2015 |
| Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K … K Bouillon, M Bertrand, G Maura, PO Blotière, P Ricordeau, M Zureik The Lancet Haematology 2 (4), e150-e159, 2015 | 116 | 2015 |
| Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study K Bouillon, M Kivimäki, M Hamer, MJ Shipley, TN Akbaraly, A Tabak, ... Journal of the American Medical Directors Association 14 (11), 851. e1-851. e6, 2013 | 101 | 2013 |
| Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study K Bouillon, F Lert, R Sitta, A Schmaus, B Spire, R Dray-Spira AIDS (London, England) 21, S89, 2007 | 83 | 2007 |
| Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study K Bouillon, GD Batty, M Hamer, S Sabia, MJ Shipley, A Britton, ... Heart, heartjnl-2012-302922, 2013 | 77 | 2013 |
| Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes K Bouillon, M Bertrand, G Bader, JP Lucot, R Dray-Spira, M Zureik JAMA 319 (4), 375-387, 2018 | 69 | 2018 |
| Metabolic syndrome and disability: findings from the prospective three-city study I Carriere, K Pérès, ML Ancelin, V Gourlet, C Berr, P Barberger-Gateau, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2013 | 66 | 2013 |
| Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study K Bouillon, A Singh-Manoux, M Jokela, MJ Shipley, GD Batty, EJ Brunner, ... Heart, hrt. 2010.216309, 2011 | 58 | 2011 |
| Validating a widely used measure of frailty: are all sub-components necessary? Evidence from the Whitehall II cohort study K Bouillon, S Sabia, M Jokela, CR Gale, A Singh-Manoux, MJ Shipley, ... Age 35 (4), 1457-1465, 2013 | 48 | 2013 |
| Association of body mass index and waist circumference with successful aging A Singh‐Manoux, S Sabia, K Bouillon, EJ Brunner, F Grodstein, A Elbaz, ... Obesity 22 (4), 1172-1178, 2014 | 37 | 2014 |
| Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study MA Bollet, F Thibault, K Bouillon, M Meunier, B Sigal-Zafrani, A Savignoni, ... International Journal of Radiation Oncology* Biology* Physics 69 (1), 13-18, 2007 | 36 | 2007 |
| Short‐Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in … K Bouillon, M Bertrand, L Boudali, P Ducimetiere, R Dray‐Spira, M Zureik Journal of the American Heart Association 5 (11), e004065, 2016 | 24 | 2016 |
| Les patients vivant avec le VIH/SIDA dans les départements français d’Amérique: résultats de l’enquête ANRS-VESPA, 2003 K Bouillon, F Lert, F Michelot, A Schmaus, B Spire, R Dray-Spira Bulletin épidémiologique hebdomadaire, 240-242, 2005 | 14 | 2005 |
| Drug-and Toxin-Induced Pulmonary Arterial Hypertension L Price, K Bouillon, SJ Wort, M Humbert Pulmonary Vascular Disorders 41, 76-84, 2012 | 4* | 2012 |
| Frailty in older age in the Whitehall II study: Measurement, validation, and predictive algorithms K Bouillon UCL (University College London), 2013 | 1 | 2013 |
| Pulmonary arterial hypertension secondary to anorexigens and other drugs and toxins K Bouillon, Y Moride, L Bensouda-Grimaldi, L Abenhaim Textbook of Pulmonary Vascular Disease, 1043-1059, 2011 | 1 | 2011 |
| Thelin Outcomes for Patient Surveillance (TOPS): post-marketing surveillance of sitaxentan in patients with pulmonary arterial hypertension P Blin, K Bouillon, L Abenhaim, N Galié EUROPEAN HEART JOURNAL 29, 561-561, 2008 | 1 | 2008 |
